119 related articles for article (PubMed ID: 38403951)
61. Neutrophil-Mediated Delivery of Dexamethasone Palmitate-Loaded Liposomes Decorated with a Sialic Acid Conjugate for Rheumatoid Arthritis Treatment.
Hu L; Luo X; Zhou S; Zhu J; Xiao M; Li C; Zheng H; Qiu Q; Lai C; Liu X; Deng Y; Song Y
Pharm Res; 2019 May; 36(7):97. PubMed ID: 31076925
[TBL] [Abstract][Full Text] [Related]
62. The selection of animal models influences the assessment of anti-tumor efficacy: promising sialic acid-conjugate modified liposomes demonstrate remarkable therapeutic effects in diverse mouse strains.
Wei L; Lin L; Wang J; Guan X; Li W; Gui Y; Liao S; Wang M; Li J; Deng Y; Song Y
Drug Deliv Transl Res; 2024 Jul; 14(7):1794-1809. PubMed ID: 38165530
[TBL] [Abstract][Full Text] [Related]
63. Synthesis and Characterization of a New Cationic Lipid: Efficient siRNA Delivery and Anticancer Activity of Survivin-siRNA Lipoplexes for the Treatment of Lung and Breast Cancers.
Vaidya S; Mohod A; Eedara AC; Andugulapati SB; Pabbaraja S
ChemMedChem; 2023 Aug; 18(16):e202300097. PubMed ID: 37306531
[TBL] [Abstract][Full Text] [Related]
64. Rational Design of Cholesterol Derivative for Improved Stability of Paclitaxel Cationic Liposomes.
Monpara J; Kanthou C; Tozer GM; Vavia PR
Pharm Res; 2018 Mar; 35(4):90. PubMed ID: 29520495
[TBL] [Abstract][Full Text] [Related]
65. Co-loaded paclitaxel/rapamycin liposomes: Development, characterization and in vitro and in vivo evaluation for breast cancer therapy.
Eloy JO; Petrilli R; Topan JF; Antonio HMR; Barcellos JPA; Chesca DL; Serafini LN; Tiezzi DG; Lee RJ; Marchetti JM
Colloids Surf B Biointerfaces; 2016 May; 141():74-82. PubMed ID: 26836480
[TBL] [Abstract][Full Text] [Related]
66. Galactose-modified cationic liposomes as a liver-targeting delivery system for small interfering RNA.
Sonoke S; Ueda T; Fujiwara K; Kuwabara K; Yano J
Biol Pharm Bull; 2011; 34(8):1338-42. PubMed ID: 21804229
[TBL] [Abstract][Full Text] [Related]
67. Poly(ethylene glycol)-block-poly(ε-caprolactone)-and phospholipid-based stealth nanoparticles with enhanced therapeutic efficacy on murine breast cancer by improved intracellular drug delivery.
He X; Li L; Su H; Zhou D; Song H; Wang L; Jiang X
Int J Nanomedicine; 2015; 10():1791-804. PubMed ID: 25784805
[TBL] [Abstract][Full Text] [Related]
68. Sequential administration of sialic acid-modified liposomes as carriers for epirubicin and zoledronate elicit stronger antitumor effects with reduced toxicity.
Sui D; Tang X; Ding J; Wang Y; Qin Y; Zhang N; Liu X; Deng Y; Song Y
Int J Pharm; 2021 Jun; 602():120552. PubMed ID: 33798685
[TBL] [Abstract][Full Text] [Related]
69. Sialic acid-conjugate modified liposomes targeting neutrophils for improved tumour therapy.
Li C; Qiu Q; Liu M; Liu X; Hu L; Luo X; Lai C; Zhao D; Zhang H; Gao X; Deng Y; Song Y
Biomater Sci; 2020 Apr; 8(8):2189-2201. PubMed ID: 32096498
[TBL] [Abstract][Full Text] [Related]
70. Tumor-derived nanovesicles promote lung distribution of the therapeutic nanovector through repression of Kupffer cell-mediated phagocytosis.
Qiu X; Li Z; Han X; Zhen L; Luo C; Liu M; Yu K; Ren Y
Theranostics; 2019; 9(9):2618-2636. PubMed ID: 31131057
[TBL] [Abstract][Full Text] [Related]
71. Engineering Lipusu with lysophosphatidylcholine for improved tumor cellular uptake and anticancer efficacy.
Li L; Zhan Q; Yi K; Chen N; Li X; Yang S; Hou X; Zhao J; Yuan X; Kang C
J Mater Chem B; 2022 Mar; 10(11):1833-1842. PubMed ID: 35212350
[TBL] [Abstract][Full Text] [Related]
72. Reversal of multidrug resistance by co-delivery of paclitaxel and lonidamine using a TPGS and hyaluronic acid dual-functionalized liposome for cancer treatment.
Assanhou AG; Li W; Zhang L; Xue L; Kong L; Sun H; Mo R; Zhang C
Biomaterials; 2015 Dec; 73():284-95. PubMed ID: 26426537
[TBL] [Abstract][Full Text] [Related]
73. Inhibition of metastatic tumor growth and metastasis via targeting metastatic breast cancer by chlorotoxin-modified liposomes.
Qin C; He B; Dai W; Zhang H; Wang X; Wang J; Zhang X; Wang G; Yin L; Zhang Q
Mol Pharm; 2014 Oct; 11(10):3233-41. PubMed ID: 24559485
[TBL] [Abstract][Full Text] [Related]
74. Delivery of Therapeutic siRNA to the CNS Using Cationic and Anionic Liposomes.
Bender HR; Kane S; Zabel MD
J Vis Exp; 2016 Jul; (113):. PubMed ID: 27501362
[TBL] [Abstract][Full Text] [Related]
75. Design, preparation and evaluation of different branched biotin modified liposomes for targeting breast cancer.
Tang B; Peng Y; Yue Q; Pu Y; Li R; Zhao Y; Hai L; Guo L; Wu Y
Eur J Med Chem; 2020 May; 193():112204. PubMed ID: 32172035
[TBL] [Abstract][Full Text] [Related]
76. Cell-penetrating corosolic acid liposome as a functional carrier for delivering chemotherapeutic drugs.
Li X; Widjaya AS; Liu J; Liu X; Long Z; Jiang Y
Acta Biomater; 2020 Apr; 106():301-313. PubMed ID: 32081779
[TBL] [Abstract][Full Text] [Related]
77. Enhanced siRNA delivery using cationic liposomes with new polyarginine-conjugated PEG-lipid.
Kim HK; Davaa E; Myung CS; Park JS
Int J Pharm; 2010 Jun; 392(1-2):141-7. PubMed ID: 20347025
[TBL] [Abstract][Full Text] [Related]
78. Tyroservatide-TPGS-paclitaxel liposomes: Tyroservatide as a targeting ligand for improving breast cancer treatment.
Jin X; Li M; Yin L; Zhou J; Zhang Z; Lv H
Nanomedicine; 2017 Apr; 13(3):1105-1115. PubMed ID: 27845234
[TBL] [Abstract][Full Text] [Related]
79. Efficacy of dual-functional liposomes containing paclitaxel for treatment of lung cancer.
Wang RH; Cao HM; Tian ZJ; Jin B; Wang Q; Ma H; Wu J
Oncol Rep; 2015 Feb; 33(2):783-91. PubMed ID: 25482610
[TBL] [Abstract][Full Text] [Related]
80. Paclitaxel-Loaded Folate-Coated pH-Sensitive Liposomes Enhance Cellular Uptake and Antitumor Activity.
Monteiro LOF; Fernandes RS; Castro L; Reis D; Cassali GD; Evangelista F; Loures C; Sabino AP; Cardoso V; Oliveira MC; Branco de Barros A; Leite EA
Mol Pharm; 2019 Aug; 16(8):3477-3488. PubMed ID: 31257891
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
